Success Metrics

Clinical Success Rate
90.9%

Based on 50 completed trials

Completion Rate
91%(50/55)
Active Trials
23(22%)
Results Posted
12%(6 trials)
Terminated
5(5%)

Phase Distribution

Ph early_phase_1
1
1%
Ph not_applicable
35
34%
Ph phase_2
2
2%
Ph phase_4
3
3%
Ph phase_1
2
2%

Phase Distribution

3

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution43 total trials
Early Phase 1First-in-human
1(2.3%)
Phase 1Safety & dosage
2(4.7%)
Phase 2Efficacy & side effects
2(4.7%)
Phase 4Post-market surveillance
3(7.0%)
N/ANon-phased studies
35(81.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

50 of 60 finished

Non-Completion Rate

16.7%

10 ended early

Currently Active

23

trials recruiting

Total Trials

104

all time

Status Distribution
Active(27)
Completed(50)
Terminated(10)
Other(17)

Detailed Status

Completed50
unknown17
Recruiting16
Active, not recruiting7
Withdrawn5
Terminated5

Development Timeline

Analytics

Development Status

Total Trials
104
Active
23
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.3%)
Phase 12 (4.7%)
Phase 22 (4.7%)
Phase 43 (7.0%)
N/A35 (81.4%)

Trials by Status

withdrawn55%
unknown1716%
completed5048%
not_yet_recruiting44%
active_not_recruiting77%
recruiting1615%
terminated55%

Recent Activity

Clinical Trials (104)

Showing 20 of 104 trialsScroll for more
NCT06230159Not Applicable

Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use

Completed
NCT05587751Not Applicable

Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

Recruiting
NCT07575880

Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care Pathway

Not Yet Recruiting
NCT05685186

A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults

Completed
NCT07253883

A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD

Not Yet Recruiting
NCT07548827

GINA-P and ACT-P Scores for Assessing Asthma Control

Not Yet Recruiting
NCT07351916

Remission in Adults With Mild-to-moderate Asthma in Thailand

Recruiting
NCT07328035

Remission in Adults With Severe Asthma in Thailand

Recruiting
NCT05876923Not Applicable

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

Recruiting
NCT03228459Not Applicable

The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease

Active Not Recruiting
NCT04972513

Impact of E-cigarette Use on the Body

Active Not Recruiting
NCT05639556

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Active Not Recruiting
NCT06521502

The APS Phenotyping Study

Recruiting
NCT04913311

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

Recruiting
NCT01501643Not Applicable

Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease

Terminated
NCT06016569Not Applicable

Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.

Recruiting
NCT07375433

Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis

Recruiting
NCT05654597

French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease

Terminated
NCT00793676Not Applicable

Asthma, Inflammation and G Protein-coupled Receptors (GPCR)

Completed
NCT03269721

COPD-Related Physiology and the Brain

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
104